Aspirin and other NSAIDs, as well as selective cyclooxygenase-2 (sCOX-2) inhibitors, may also prevent HL development by suppressing the proliferative, angiogenic effects of COX-2, which is overexpressed in HL (Ohsawa et al, 2006). Here, PTGS2 is linked to Hodgkins lymphoma.